Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Murphy

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|July 4, 1998
False-positive self-reports of HIV-1 infectionC Chintu, K S Baboo, S S Gould, et al.
Targeted Diagnosis and Therapy|January 1, 1992
Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human diseaseJ R Murphy, F G Lakkis, J C vanderSpek, et al.
Journal of Bacteriology|January 1, 1995
Molecular cloning, DNA sequence analysis, and characterization of the Corynebacterium diphtheriae dtxR homolog from Brevibacterium lactofermentumJ A Oguiza, X Tao, A T Marcos, et al.
Protein Engineering|April 1, 1991
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cellsT Kiyokawa, D P Williams, C E Snider, et al.
Life Sciences|October 27, 1986
Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretionM S Blank, D R Mann, D T Daugherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 1999
Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressorY C Manabe, B J Saviola, L Sun, et al.
Leukemia|April 1, 1994
Epitope tagging of DAB389IL-2: new insights into C-domain delivery to the cytosol of target cellsJ van der Spek, A Hémard, A Dautry-Varsat, et al.
Leukemia & Lymphoma|October 1, 1993
Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cellsD E Chadwick, D P Williams, Y Niho, et al.
Annual Review of Medicine|January 1, 1993
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting moleculesT B Strom, V R Kelley, J R Murphy, et al.
Journal of Clinical Microbiology|July 1, 1989
Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infectionJ R Murphy, S Baqar, J R Davis, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|July 4, 1998
False-positive self-reports of HIV-1 infectionC Chintu, K S Baboo, S S Gould, et al.
Targeted Diagnosis and Therapy|January 1, 1992
Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human diseaseJ R Murphy, F G Lakkis, J C vanderSpek, et al.
Journal of Bacteriology|January 1, 1995
Molecular cloning, DNA sequence analysis, and characterization of the Corynebacterium diphtheriae dtxR homolog from Brevibacterium lactofermentumJ A Oguiza, X Tao, A T Marcos, et al.
Protein Engineering|April 1, 1991
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cellsT Kiyokawa, D P Williams, C E Snider, et al.
Life Sciences|October 27, 1986
Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretionM S Blank, D R Mann, D T Daugherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 1999
Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressorY C Manabe, B J Saviola, L Sun, et al.
Leukemia|April 1, 1994
Epitope tagging of DAB389IL-2: new insights into C-domain delivery to the cytosol of target cellsJ van der Spek, A Hémard, A Dautry-Varsat, et al.
Leukemia & Lymphoma|October 1, 1993
Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cellsD E Chadwick, D P Williams, Y Niho, et al.
Annual Review of Medicine|January 1, 1993
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting moleculesT B Strom, V R Kelley, J R Murphy, et al.
Journal of Clinical Microbiology|July 1, 1989
Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infectionJ R Murphy, S Baqar, J R Davis, et al.
Pageof 29